WebThe common indications for warfarinisation are atrial fibrillation, venous thromboembolism and prosthetic heart valves. Contraindications include absolute and relative contraindications, and an individualised risk-benefit analyses is required for each patient. There are many interactions with warfarin, including pharmacokinetic and … WebOct 13, 2024 · Manufacturers and some authorities recommend use in patients with end-stage kidney disease who currently are undergoing hemodialysis or peritoneal dialysis therapy and also in predialysis patients with CKD who have a hematocrit <30% or hemoglobin concentration <10 g/dL.
Food and Drug Administration
WebDepending on the country in which Epoetin alfa is marketed, these indications may differ. Important U.S. Safety Information for PROCRIT. From the Boxed Warnings. Use the lowest dose of PROCRIT that will gradually increase the hemoglobin (Hb) concentration to the lowest level sufficient to avoid the need for red blood cell (RBC) transfusion. WebJun 21, 2024 · In pregnant women, lactating women, neonates, and infants use only single-dose vials (the benzyl alcohol-free formulation) [see Contraindications ( 4) and Use in Specific Populations ( 8.1, 8.2, and 8.4 )]. Patients with Chronic Kidney Disease liesbeth sijtsma
Procrit: Package Insert - Drugs.com
WebFeb 17, 2024 · Canadian labeling: Additional contraindications (not in the US labelings): Known hypersensitivity to mammalian cell-derived products or any component of the formulation; patients who for any reason cannot receive adequate antithrombotic treatment; use in patients with severe coronary, peripheral arterial, carotid, or cerebral vascular … WebJun 22, 2011 · HORSHAM, Pa., June 24, 2011 /PRNewswire/ -- Janssen Products, LP, formerly Centocor Ortho Biotech Products, L.P., today announced updated prescribing information for PROCRIT® (Epoetin alfa) when used to treat anemia associated with chronic kidney disease (CKD) as part of a U.S. Food and Drug Administration (FDA)-approved … liesbeth seraphin